SERPINB5 promotes apoptotic events of invasive prostate and breast carcinoma cells [41] and down-regulation of its expression causes pancreatic, colorectal, and ovarian adenocarcinomas [42]. This evidence concerns the gene SERPINB5 and ovarian adenocarcinoma.